Is the Current Threshold for Diagnosis of "Abnormality", Including Non ST Elevation Myocardial Infarction, Using Raised Highly Sensitive Troponin Appropriate for a Hospital Population? The CHARIOT Study
CHARIOT
1 other identifier
observational
20,000
1 country
1
Brief Summary
Currently when defining the upper limit of normal (ULN) or 99th percentile of a troponin assay manufacturer's use a healthy population traditionally aged 18-40. The 99th percentile value is the recommended value to use when diagnosing patients with an acute myocardial infarction. With the advent of the new highly sensitive troponin assays it has become clear that many patients have a troponin level above the 99th percentile when they have not suffered a myocardial infarction. We believe part of the problem with interpreting the the troponin values for patients is that the 99th percentile value which determines the ULN has been derived from population that is very different to the hospital population of patients. This study aims to demonstrate what the 99th percentile is for the population of people who use the hospital services who are traditionally older and have more comorbidities when compared to the population traditionally used to define the 99th percentile of a troponin assay. An amendment was approved to follow-up patients' clinical outcomes at 1 year using NHS Digital data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 8, 2017
CompletedFirst Posted
Study publicly available on registry
February 9, 2017
CompletedStudy Start
First participant enrolled
June 29, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedDecember 11, 2020
December 1, 2020
5 months
February 8, 2017
December 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The 99th percentile for the hospital population.
Distribution and 99th centile for hsTnI BC assay in 20000 consecutive patients having a biochemistry blood test at a large teaching hospital
6 months
Secondary Outcomes (2)
The 99th percentile in different variables.
6 months
The 99th percentile in different variables.
12 months
Study Arms (1)
Hospital population
All patients who have had a biochemistry blood tests requested at the trust will have a troponin blood level determined.
Eligibility Criteria
All consecutive patients (inpatients or outpatients) who have had a biochemistry sample requested by a hospital clinician as part of their routine clinical care. A total of 20,000 consecutive patients will be recruited.
You may qualify if:
- Adult patients (aged 18 years or older).
- Biochemistry blood sample already taken as part of routine clinical care.
You may not qualify if:
- Individuals aged less than 18 years old.
- No biochemistry blood sample taken as part of routine clinical care.
- Biochemistry samples requested by General Practitioner
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Southampton General Hospital
Southampton, SO16 6YD, United Kingdom
Related Publications (1)
Mariathas M, Allan R, Ramamoorthy S, Olechowski B, Hinton J, Azor M, Nicholas Z, Calver A, Corbett S, Mahmoudi M, Rawlins J, Simpson I, Wilkinson J, Kwok CS, Cook P, Mamas MA, Curzen N. True 99th centile of high sensitivity cardiac troponin for hospital patients: prospective, observational cohort study. BMJ. 2019 Mar 13;364:l729. doi: 10.1136/bmj.l729.
PMID: 30867154DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nick Curzen, BM, PhD
Southampton NHS Trust
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2017
First Posted
February 9, 2017
Study Start
June 29, 2017
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
December 11, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share